Home / Research Library / Segmentectomy versus lobectomy in small-sized peri...
🧬 Medicine & Biology OpenAlex

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

📅 April 1, 2022 👤 Hisashi Saji, Morihito Okada, Masahiro Tsuboi et al. 📖 The Lancet 📊 1,635 citations

🤖 Plain-English Summary

This research explores Segmentectomy versus lobectomy in small-sized peripheral non..., contributing new insights to the field of Medicine & Biology.

🔑 Key Findings

  • Research demonstrates significant advances in patient outcome data
  • Study provides new evidence regarding clinical efficacy results
  • Findings open new directions for biological mechanism insights

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Apr 01, 2022
Journal The Lancet
Authors Hisashi Saji, Morihito Okada, Masahiro Tsuboi, Ryu Nakajima, Kenji Suzuki
DOI 10.1016/s0140-6736(21)02333-3
Citations 1,635
Source OpenAlex

More 🧬 Medicine & Biology Research